The efficacy and safety of opioids in inflammatory arthritis: A Cochrane systematic review

Journal of Rheumatology

Volumn 39, Issue SUPPL. 90, 2012, Pages 40-46

  Whittle, Samuel L ^a   Richards, Bethan L ^b   Van Der Heijde, Désirée M ^c   Buchbinder, Rachelle ^d,e  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CABRINI HOSPITAL   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

Opioid; Rheumatoid arthritis; Systematic review

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; CODEINE; DEXTROPROPOXYPHENE; DICLOFENAC; INDOMETACIN; MORPHINE SULFATE; NALOXONE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENTAZOCINE; PHENACETIN; PLACEBO; SARIDON; TILIDINE; TRAMADOL;

ARTHRITIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HEMATEMESIS; HUMAN; INFLAMMATORY ARTHRITIS; MELENA; PAIN; PAIN ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SYSTEMATIC REVIEW; THORAX PAIN; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING; ANALGESIA; EVIDENCE BASED MEDICINE; EXPERT WITNESS; INTERNATIONAL COOPERATION; METHODOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATOID ARTHRITIS;

ANALGESICS, OPIOID; ARTHRITIS, RHEUMATOID; EVIDENCE-BASED MEDICINE; EXPERT TESTIMONY; HUMANS; INTERNATIONAL COOPERATION; PAIN; PAIN MANAGEMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84865838620     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120341     Document Type: Review

References (36)

1. Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 2004;22 Suppl 1:1-12.
2. Minnock P, FitzGerald O, Bresnihan B. Women with established rheumatoid arthritis perceive pain as the predominant impairment of health status. Rheumatology 2003;42:995-1000.
3. Heiberg T, Kvien TK. Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: Pain has highest priority. Arthritis Rheum 2002;47:391-7.
4. Hudcova J, McNicol E, Quah C, Lau J, Carr DB. Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain. Cochrane Database Syst Rev 2006;4:CD003348.
5. Wiffen PJ, McQuay HJ. Oral morphine for cancer pain. Cochrane Database Syst Rev 2007;4:CD003868.
6. Grijalva CG, Chung CP, Stein CM, Mitchel EF Jr, Griffin MR. Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population. Rheumatology 2008;47:1061-4.
7. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 2002;46:328-46.
8. Luqmani R, Hennell S, Estrach C, Basher D, Birrell F, Bosworth A, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology 2009;48:436-9.
9. Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006;65:442-52.
10. Fitzcharles MA, DaCosta D, Ware MA, Shir Y. Patient barriers to pain management may contribute to poor pain control in rheumatoid arthritis. J Pain 2009;10:300-5.
11. Whittle SL, Richards BL, Husni E, Buchbinder R. Opioid therapy for treating rheumatoid arthritis pain. Cochrane Database Syst Rev 2011;11:CD003113.
12. Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions, Version 5.0.2 (updated September 2009). The Cochrane Collaboration; 2009.
13. Sackett DL, Richardson WS, Rosenberg WM, Haynes RB. Evidence-based medicine: How to practice and teach EBM. London, UK: Churchill Livingstone; 1997.
14. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 1992;260:275-85.
15. Goldman A, Hain R, Liben S. Oxford textbook of palliative care for children. Oxford: Oxford University Press; 2006.
16. Deeks JJ, Higgins JP, Altman DG. Analysing data and undertaking meta-analyses. Ch 9. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions. Cochrane Book Series. Chichester, UK: John Wiley & Sons, Ltd.; 2008; doi:10.1002/9780470712184.
17. Boada JN, Boada C, Garcia-Saiz M, Garcia M, Fernandez E, Gomez E. Net efficacy adjusted for risk (NEAR): A simple procedure for measuring risk:benefit balance. PloS one 2008;3:e3580.
18. Lee EY, Lee EB, Park BJ, Lee CK, Yoo B, Lim MK, et al. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: A 1-week, randomized, double-blind, placebo-controlled trial. Clin Ther 2006;28:2052-60.
19. Bedi SS. Comparison of aspirin and dextropropoxyphene-with-aspirin as analgesics in rheumatoid arthritis. Br J Clin Pract 1969;23:413-7.
20. Hardin JG Jr, Kirk KA. Comparative effectiveness of five analgesics for the pain of rheumatoid synovitis. J Rheumatol 1979;6:405-12.
21. Hill RC, Turner P. A comparison of codeine compound and "saridone" in the pain of rheumatoid arthritis. Br J Clin Pract 1970;24:29-32.
22. Huskisson EC. Simple analgesics for arthritis. BMJ 1974;4:196-200.
23. Moran C. MST continuous tablets and pain control in severe rheumatoid arthritis. Br J Clin Res 1991;2:1-12.
24. Nuki G, Downie WW, Dick WC, Whaley K, Spooner JB, Darby Dowman MA, et al. Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos. Ann Rheum Dis 1973;32:436-43.
25. Saarialho Kere U, Julkunen H, Mattila MJ, Seppälä T. Psychomotor performance of patients with rheumatoid arthritis: Cross-over comparison of dextropropoxyphene, dextropropoxyphene plus amitriptyline, indomethacin, and placebo. Pharmacol Toxicol 1988;63:286-92.
26. Boureau F, Boccard E. Placebo-controlled study of the analgesic efficacy of a combination of paracetamol and codeine in rheumatoid arthritis. Acta Ther 1991;17:123-36.
27. Brunnmuller U, Zeidler H, Alten R, Gromnica Ihle E. Effective analgesic therapy with tilidine/naloxone for patients with rheumatoid arthritis [German]. Aktuelle Rheumatologie 2004;29:35-9.
28. Glowinski J, Boccard E. Placebo-controlled study of the analgesic efficacy of a paracetamol 500 mg/Codeine 30 mg combination together with low-dose vs high-dose diclofenac in rheumatoid arthritis. Clin Drug Invest 1999;18:189-97.
29. Whittle SL, Colebatch AN, Buchbinder R, Edwards CJ, Adams K, Englbrecht M, et al. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: Integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology 2012 Mar 24. [Epub ahead of print]
30. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008;9:105-21.
31. Moore RA, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al. "Evidence" in chronic pain - establishing best practice in the reporting of systematic reviews. Pain 2010;150:386-9.
32. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. CMAJ 2006;174:1589-94.
33. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: Molecular mechanisms and clinical considerations. Clin J Pain 2008;24:479-96.
34. Rhodin A, Stridsberg M, Gordh T. Opioid endocrinopathy: A clinical problem in patients with chronic pain and long-term oral opioid treatment. Clin J Pain 2010;26:374-80.
35. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010;1:CD006605.
36. Moore RA, Derry S, McQuay HJ, Straube S, Aldington D, Wiffen P, et al. Clinical effectiveness: An approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences. Pain 2010;149:173-6.